4,848,485 SHARES OF COMMON STOCK of IMMUNOMEDICS, INC. PLACEMENT AGENT AGREEMENTAgent Agreement • May 2nd, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
SUBSCRIPTION AGREEMENTSubscription Agreement • May 2nd, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
[ ] A. Delivery by crediting the account of the Investor’s prime broker (as specified by the Investor on Exhibit A annexed hereto) with the Depository Trust Company (“DTC”) through its Deposit/Withdrawal At Custodian (“DWAC”) system, whereby the Investor’s prime broker shall initiate a DWAC transaction on the Closing Date using its DTC participant identification number and released by American Stock Transfer and Trust Company, the Company’s transfer agent (the “Transfer Agent”), at the Company’s direction. NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR AND THE COMPANY, THE INVESTOR SHALL:
